Point72 (DIFC)’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
EC
Point72 (DIFC)'s JAZZ Position: Q3 2025 in Review
Point72 (DIFC) opened a new position in Jazz Pharmaceuticals (JAZZ) in Q3 2025: 99 shares worth $13K. The stake represents ﹤0.01% of the portfolio and ranks #918 among its holdings. This is a return to the name: Point72 (DIFC) previously reported a position in JAZZ as recently as Q1 2025.
Point72 (DIFC) first reported a position in JAZZ in Q2 2024 and has held it in 4 quarters since. The position peaked at $1.82M in Q2 2024. 503 funds tracked by Wall St. Rank hold JAZZ as of Q3 2025.
- Point72 (DIFC) held 99 shares of Jazz Pharmaceuticals worth $13K as of Q3 2025.
- Jazz Pharmaceuticals was a new Point72 (DIFC) position in Q3 2025.
- Jazz Pharmaceuticals made up ﹤0.01% of Point72 (DIFC)'s portfolio in Q3 2025, its #918 holding.
- Point72 (DIFC) first reported a position in Jazz Pharmaceuticals in Q2 2024 and has held it in 4 quarters since.
- Point72 (DIFC)'s Jazz Pharmaceuticals position peaked at $1.82M in Q2 2024.
- 503 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2025.
Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.